Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
Holding SLNO?
Track your performance easily
SLNO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$21.30 - $56.81
Previous Close$54.92
Volume553.18K
Average Volume (3M)608.37K
Market Cap
$2.13B
Enterprise Value$1.87B
Total Cash (Recent Filing)$266.12M
Total Debt (Recent Filing)$296.00K
Price to Earnings (P/E)―
Beta-0.78
Next Earnings
Nov 06, 2024EPS Estimate
-$0.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.43
Shares Outstanding38,871,594
10 Day Avg. Volume565,843
30 Day Avg. Volume608,365
Standard Deviation0.70
R-Squared0.01
Alpha0.12
Financial Highlights & Ratios
Price to Book (P/B)7.59
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-30.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-37.23
Forecast
1Y Price Target
$73.71Price Target Upside34.21% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Soleno Therapeutics News
PremiumPre-Earnings
Is SLNO a Buy, Before Earnings?
Ownership Overview
19.72% Insiders
9.75% Mutual Funds
0.03% Other Institutional Investors
61.15% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SLNO FAQ
What was Soleno Therapeutics Inc’s price range in the past 12 months?
Soleno Therapeutics Inc lowest stock price was $21.30 and its highest was $56.81 in the past 12 months.
What is Soleno Therapeutics Inc’s market cap?
Currently, no data Available
When is Soleno Therapeutics Inc’s upcoming earnings report date?
Soleno Therapeutics Inc’s upcoming earnings report date is Nov 06, 2024 which is 4 days ago.
How were Soleno Therapeutics Inc’s earnings last quarter?
Soleno Therapeutics Inc released its earnings results on Aug 07, 2024. The company reported -$0.57 earnings per share for the quarter, missing the consensus estimate of -$0.567 by -$0.003.
Is Soleno Therapeutics Inc overvalued?
According to Wall Street analysts Soleno Therapeutics Inc’s price is currently Undervalued.
Does Soleno Therapeutics Inc pay dividends?
Soleno Therapeutics Inc does not currently pay dividends.
What is Soleno Therapeutics Inc’s EPS estimate?
Soleno Therapeutics Inc’s EPS estimate is -$0.61.
How many shares outstanding does Soleno Therapeutics Inc have?
Soleno Therapeutics Inc has 38,871,593 shares outstanding.
What happened to Soleno Therapeutics Inc’s price movement after its last earnings report?
Soleno Therapeutics Inc reported an EPS of -$0.57 in its last earnings report, missing expectations of -$0.567. Following the earnings report the stock price went up 2.548%.
Which hedge fund is a major shareholder of Soleno Therapeutics Inc?
Among the largest hedge funds holding Soleno Therapeutics Inc’s share is Perceptive Advisors LLC. It holds Soleno Therapeutics Inc’s shares valued at 131M.
---
Soleno Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$73.71 (34.21% Upside)
$73.71 (34.21% Upside)
Blogger Sentiment
Bullish
SLNO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 470.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $65.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.3%
Last 30 Days ▲ 10.6%
Last 30 Days ▲ 10.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
128.83%
12-Months-Change
Fundamentals
Return on Equity
-44.62%
Trailing 12-Months
Asset Growth
882.84%
Trailing 12-Months
Company Description
Soleno Therapeutics Inc
Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It markets CoSense End-Tidal Carbon Monoxide monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns. The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
---
SLNO Stock 12 Month Forecast
Average Price Target
$73.71
▲(34.21% Upside)
Technical Analysis
Best Analysts Covering SLNO
1 Year
1 Year Success Rate
12/23 ratings generated profit
1 Year Average Return
+156.94%
reiterated a buy rating last month
Copying Leland Gershell's trades and holding each position for 1 Year would result in 52.17% of your transactions generating a profit, with an average return of +156.94% per trade.
---